Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025

Global Familial Mediterranean Fever Pharmaceuticals Market Report 2025

Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025 - By Drug Type (Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs), By Route Of Administration (Oral, Injectable), By End Users (Hospitals, Clinical Diagnostic Laboratories, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Name: Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : May 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Familial Mediterranean Fever Pharmaceuticals Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Familial Mediterranean Fever Pharmaceuticals Market?

Familial mediterranean fever (FMF) pharmaceuticals refer to medications used to manage and treat FMF, a genetic disorder characterized by recurrent fever and inflammation, often affecting the abdomen, chest, and joints. The primary goal of these pharmaceuticals is to reduce the frequency and severity of attacks and prevent long-term complications, such as amyloidosis.

The main familial mediterranean fever pharmaceuticals are colchicine, Interleukin-1 Inhibitors, and anti-il-6 drugs. Colchicine is a medication that helps reduce inflammation and prevent flare-ups in conditions like gout and other inflammatory disorders. It can be administered through both oral and injectable channels and is used by various end users including hospitals, clinical diagnostic laboratories, and others.

Familial Mediterranean Fever Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

What Is The Familial Mediterranean Fever Pharmaceuticals Market Size 2025 And Growth Rate?

The familial mediterranean fever pharmaceuticals market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rise in the disease prevalence, rise in the migration, rise in the geriatric population, increasing cases of genetic aberrations within the MEFV gene, and rise in genetic mutation.

What Is The Familial Mediterranean Fever Pharmaceuticals Market Growth Forecast?

The familial mediterranean fever pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increase in the adoption of advanced cancer therapeutic options, growing interest in gene therapy and biologics, rise in adoption of advanced therapy, inflating utilization of effective medications, and widespread adoption of supportive therapies. Major trends in the forecast period include advancements in treatment, introduction of newer drug classes, collaboration between academic institutions, research organizations, and pharmaceutical companies, adaptation of new therapeutics, and development in technology.

Book your 30 minutes free consultation with our research experts

How Is The Familial Mediterranean Fever Pharmaceuticals Market Segmented?

The familial mediterranean fever pharmaceuticals market covered in this report is segmented –

1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs

2) By Route Of Administration: Oral, Injectable

3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users

Subsegments:

1) By Colchicine: Oral Colchicine, Intravenous Colchicine

2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept

3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab

What Is Driving The Familial Mediterranean Fever Pharmaceuticals Market? Rise In Gene Therapy Driving The Growth Of The Market Due To Advancements In Genetic Engineering

The rise in gene therapy is expected to drive the growth of the familial Mediterranean fever (FMF) pharmaceuticals market going forward. Gene therapy is a medical approach that modifies or replaces faulty genes to treat or prevent diseases at the genetic level. The rise in gene therapy is due to advancements in genetic engineering, which enable precise targeting and correction of genetic disorders, offering potential cures for previously untreatable diseases. Gene therapy positively impacts familial mediterranean fever (FMF) pharmaceuticals by targeting the root cause mutations in the MEFV (Mediterranean fever) gene, potentially providing a long-term or permanent cure rather than symptom management. For instance, in July 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit organization, 76 gene therapy trials were initiated in the second quarter of 2024, a 25% increase from the previous quarter. Therefore, the rise in gene therapy is driving the growth of the familial Mediterranean fever (FMF) pharmaceuticals market.

Who Are The Major Players In The Global Familial Mediterranean Fever Pharmaceuticals Market?

Major companies operating in the familial mediterranean fever pharmaceuticals market are Merck & Co. Inc., Bristol Myers Squibb, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Swedish Orphan Biovitrum AB (Sobi), Granules Pharmaceuticals Inc., Sanmar Group, Indena S.p.A., Harman Finochem, Camber Pharmaceuticals Inc., R-Pharm Group, Alchem International, AdvaCare Pharma USA LLC, ViennaLab Diagnostics GmbH, Honour Lab Ltd., Vital Laboratories Pvt. Ltd., Enomark Biotech Pvt. Ltd., Gonane Pharma, Ennature Biopharma

What Are The Key Trends Of The Global Familial Mediterranean Fever Pharmaceuticals Market? Advancements In Treatments Focus On Cost-Effective Alternatives And Innovative Therapies To Improve Patient Outcomes

Major companies operating in the familial mediterranean fever (FMF) pharmaceuticals market are focusing on developing advanced treatments, such as cost-effective generic alternatives, to explore novel biologics and gene therapies. A cost-effective generic alternative is a lower-cost version of a brand-name drug that maintains the same active ingredients, dosage, safety, and effectiveness. For instance, in January 2022, Camber Pharmaceuticals Inc., a US-based pharmaceutical manufacturing company, launched generic Colcrys (colchicine) tablets, expanding its product portfolio. These tablets are used for treating and preventing familial mediterranean fever (FMF) in adults and children aged four and older and for managing gout flares. Available in 0.6 mg strength, they come in 30- and 100-count bottles. This launch supports Camber’s commitment to delivering high-quality, affordable generic medications to enhance patient care.

What Are Latest Mergers And Acquisitions In The Familial Mediterranean Fever Pharmaceuticals Market? Sobi Partners With Acino For Exclusive Distribution Of Rare Disease Treatments In Kazakhstan

In January 2024, Swedish Orphan Biovitrum AB, a Sweden-based manufacturer of Interleukin-1 inhibitors, partnered with Acino International AG. The partnership enables Acino to distribute Sobi’s specialized rare disease treatments exclusively in Kazakhstan, expanding access to innovative therapies. Acino International AG is a Switzerland-based pharmaceutical company specializing in developing, manufacturing, and distributing high-quality generic and specialty medicines.

What Is The Regional Outlook For The Global Familial Mediterranean Fever Pharmaceuticals Market?

Middle East was the largest region in the familial mediterranean fever pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the familial mediterranean fever pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the familial mediterranean fever pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Familial Mediterranean Fever Pharmaceuticals Market?

The familial mediterranean fever pharmaceuticals market consists of sales of NSAIDs, corticosteroids, immunosuppressants, disease-modifying antirheumatic drugs, and pain management medications used to manage inflammation and prevent complications in familial mediterranean fever patients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Familial Mediterranean Fever Pharmaceuticals Industry?

The sarcoidosis market research report is one of a series of new reports from The Business Research Company that provides sarcoidosis market statistics, including sarcoidosis industry global market size, regional shares, competitors with a sarcoidosis market share, detailed sarcoidosis market segments, market trends and opportunities, and any further data you may need to thrive in the sarcoidosis industry. This sarcoidosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Familial Mediterranean Fever Pharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.74 billion
Revenue Forecast In 2034	$2.15 billion
Growth Rate	CAGR of 5.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The familial mediterranean fever pharmaceuticals market covered in this report is segmented – 1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs 2) By Route Of Administration: Oral, Injectable 3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users Subsegments: 1) By Colchicine: Oral Colchicine, Intravenous Colchicine 2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept 3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Familial Mediterranean Fever Pharmaceuticals Market Characteristics

3. Familial Mediterranean Fever Pharmaceuticals Market Trends And Strategies

4. Familial Mediterranean Fever Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Familial Mediterranean Fever Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Familial Mediterranean Fever Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Familial Mediterranean Fever Pharmaceuticals Market Growth Rate Analysis

5.4. Global Familial Mediterranean Fever Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Familial Mediterranean Fever Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Familial Mediterranean Fever Pharmaceuticals Total Addressable Market (TAM)

6. Familial Mediterranean Fever Pharmaceuticals Market Segmentation

6.1. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Colchicine

Interleukin-1 Inhibitors

Anti-IL-6 Drugs

6.2. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

6.3. Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinical Diagnostic Laboratories

Other End Users

6.4. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Colchicine

Intravenous Colchicine

6.5. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anakinra

Canakinumab

Rilonacept

6.6. Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tocilizumab

Sarilumab

Siltuximab

7. Familial Mediterranean Fever Pharmaceuticals Market Regional And Country Analysis

7.1. Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market

8.1. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Familial Mediterranean Fever Pharmaceuticals Market

9.1. China Familial Mediterranean Fever Pharmaceuticals Market Overview

9.2. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Familial Mediterranean Fever Pharmaceuticals Market

10.1. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Familial Mediterranean Fever Pharmaceuticals Market

11.1. Japan Familial Mediterranean Fever Pharmaceuticals Market Overview

11.2. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Familial Mediterranean Fever Pharmaceuticals Market

12.1. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Familial Mediterranean Fever Pharmaceuticals Market

13.1. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Familial Mediterranean Fever Pharmaceuticals Market

14.1. South Korea Familial Mediterranean Fever Pharmaceuticals Market Overview

14.2. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Familial Mediterranean Fever Pharmaceuticals Market

15.1. Western Europe Familial Mediterranean Fever Pharmaceuticals Market Overview

15.2. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Familial Mediterranean Fever Pharmaceuticals Market

16.1. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Familial Mediterranean Fever Pharmaceuticals Market

17.1. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Familial Mediterranean Fever Pharmaceuticals Market

18.1. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Familial Mediterranean Fever Pharmaceuticals Market

19.1. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Familial Mediterranean Fever Pharmaceuticals Market

20.1. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market

21.1. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market Overview

21.2. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Familial Mediterranean Fever Pharmaceuticals Market

22.1. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Familial Mediterranean Fever Pharmaceuticals Market

23.1. North America Familial Mediterranean Fever Pharmaceuticals Market Overview

23.2. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Familial Mediterranean Fever Pharmaceuticals Market

24.1. USA Familial Mediterranean Fever Pharmaceuticals Market Overview

24.2. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Familial Mediterranean Fever Pharmaceuticals Market

25.1. Canada Familial Mediterranean Fever Pharmaceuticals Market Overview

25.2. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Familial Mediterranean Fever Pharmaceuticals Market

26.1. South America Familial Mediterranean Fever Pharmaceuticals Market Overview

26.2. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Familial Mediterranean Fever Pharmaceuticals Market

27.1. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Familial Mediterranean Fever Pharmaceuticals Market

28.1. Middle East Familial Mediterranean Fever Pharmaceuticals Market Overview

28.2. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Familial Mediterranean Fever Pharmaceuticals Market

29.1. Africa Familial Mediterranean Fever Pharmaceuticals Market Overview

29.2. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Familial Mediterranean Fever Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Familial Mediterranean Fever Pharmaceuticals Market Competitive Landscape

30.2. Familial Mediterranean Fever Pharmaceuticals Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Familial Mediterranean Fever Pharmaceuticals Market Other Major And Innovative Companies

31.1. Swedish Orphan Biovitrum AB (Sobi)

31.2. Granules Pharmaceuticals Inc.

31.3. Sanmar Group

31.4. Indena S.p.A.

31.5. Harman Finochem

31.6. Camber Pharmaceuticals Inc.

31.7. R-Pharm Group

31.8. Alchem International

31.9. AdvaCare Pharma USA LLC

31.10. ViennaLab Diagnostics GmbH

31.11. Honour Lab Ltd.

31.12. Vital Laboratories Pvt. Ltd.

31.13. Enomark Biotech Pvt. Ltd.

31.14. Gonane Pharma

31.15. Ennature Biopharma

32. Global Familial Mediterranean Fever Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Familial Mediterranean Fever Pharmaceuticals Market

34. Recent Developments In The Familial Mediterranean Fever Pharmaceuticals Market

35. Familial Mediterranean Fever Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Familial Mediterranean Fever Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Merck & Co. Inc. Financial Performance

Table 78: Bristol Myers Squibb Financial Performance

Table 79: Novartis International AG Financial Performance

Table 80: Takeda Pharmaceutical Company Limited Financial Performance

Table 81: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Colchicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Interleukin-1 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Familial Mediterranean Fever Pharmaceuticals Market, Sub-Segmentation Of Anti-IL-6 Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Familial Mediterranean Fever Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Familial Mediterranean Fever Pharmaceuticals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Merck & Co. Inc. Financial Performance

Figure 78: Bristol Myers Squibb Financial Performance

Figure 79: Novartis International AG Financial Performance

Figure 80: Takeda Pharmaceutical Company Limited Financial Performance

Figure 81: Amgen Inc. Financial Performance

How is the Anti-Aging Market Poised for Growth: Trends and Opportunities Through 2034

What’s Driving Growth in the Anticoagulants Market? Insights into Key Trends and Opportunities

Comprehensive Analysis of the Biomarkers Market 2025-2034: Growth Rates, Trends, and Future Opportunities

How Will the Botanical Supplements Market Grow? Key Trends and Opportunities for 2025 and Beyond

Cancer Immunotherapy Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Comprehensive Analysis of the Compression Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Unlocking the Future of the Contraceptives Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Contract Development Manufacturing Organizations Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

Generic Pharmaceuticals Market 2024 – By Type (Biosimilars, Generics), By Therapy (Oncology Drugs, Central Nervous System Drugs, Anti-Infective Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Others), By Drug Delivery (Oral, Injectables, Dermal/Topical, Other Drug Delivery), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2033

View Report

Veterinary Pharmaceuticals Market 2024 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock Animals, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administration), By End-User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores), And By Region, Opportunities And Strategies – Global Forecast To 2033

View Report

AI-Based Fever Detection Camera Global Market Report 2025 – By Component (Hardware, Software, Services), By Type (Turret Or Bullet Cameras, Handheld Cameras), By Resolution (High Resolution Camera, Medium Resolution Camera, Low Resolution Camera), By End-User (Airports, Hospitals, Public Places, Enterprises Or Factories, Banks, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Generic Pharmaceuticals Global Market Report 2025 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administration), By End User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Companion Animal Pharmaceuticals Global Market Report 2025 – By Animal Type (Dogs, Cats, Horses, Other Companion Animals ), By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications ), By Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Ethical Pharmaceuticals Global Market Report 2025 – By Type( Lipid Regulators, Narcotic Analgesics, ACE Inhibitors, Respiratory Agents, Diuretics, Calcium Antagonists, Hormonal Contraceptives, Penicillin, Vitamin, Minerals ), By Distribution Channel( Hospital Pharmacy, Retail Pharmacies, Other Distribution Channels), By Application( Hospitals And Clinics, Pharmaceutical Company) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mid-Size Pharmaceuticals Global Market Report 2025 – By Drug Development Type (In-House, Outsource), By Type (Prescription, Over the Counter), By Formulation (Tablets, Capsules, Injectables, Sprays, Other Formulations), By Application (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Familial Mediterranean Fever Pharmaceuticals market?

How will the Familial Mediterranean Fever Pharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Familial Mediterranean Fever Pharmaceuticals industry going forward?

The Familial Mediterranean Fever Pharmaceuticals market major growth driver - Rise In Gene Therapy Driving The Growth Of The Market Due To Advancements In Genetic Engineering. For further insights on the Familial Mediterranean Fever Pharmaceuticals market, request a sample here

What is the forecast market size or the forecast market value of the Familial Mediterranean Fever Pharmaceuticals market?

The Familial Mediterranean Fever Pharmaceuticals market size has grown strongly in recent years. The familial mediterranean fever pharmaceuticals market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rise in the disease prevalence, rise in the migration, rise in the geriatric population, increasing cases of genetic aberrations within the MEFV gene, and rise in genetic mutation. The familial mediterranean fever pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increase in the adoption of advanced cancer therapeutic options, growing interest in gene therapy and biologics, rise in adoption of advanced therapy, inflating utilization of effective medications, and widespread adoption of supportive therapies. Major trends in the forecast period include advancements in treatment, introduction of newer drug classes, collaboration between academic institutions, research organizations, and pharmaceutical companies, adaptation of new therapeutics, and development in technology. For further insights on the Familial Mediterranean Fever Pharmaceuticals market, request a sample here

How is the Familial Mediterranean Fever Pharmaceuticals market segmented?

The familial mediterranean fever pharmaceuticals market covered in this report is segmented –
1) By Drug Type: Colchicine, Interleukin-1 Inhibitors, Anti-IL-6 Drugs
2) By Route Of Administration: Oral, Injectable
3) By End Users: Hospitals, Clinical Diagnostic Laboratories, Other End Users

Subsegments:
1) By Colchicine: Oral Colchicine, Intravenous Colchicine
2) By Interleukin-1 Inhibitors: Anakinra, Canakinumab, Rilonacept
3) By Anti-IL-6 Drugs: Tocilizumab, Sarilumab, Siltuximab For further insights on the Familial Mediterranean Fever Pharmaceuticals market, request a sample here

Which region has the largest share of the Familial Mediterranean Fever Pharmaceuticals market? What are the other regions covered in the report?

Who are the major players in the Familial Mediterranean Fever Pharmaceuticals market?

. For further insights on the Familial Mediterranean Fever Pharmaceuticals market, request a sample here.

What are the key trends in the Familial Mediterranean Fever Pharmaceuticals market?

Major trends in the Familial Mediterranean Fever Pharmaceuticals market include Middle East was the largest region in the familial mediterranean fever pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the familial mediterranean fever pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.. For further insights on the Familial Mediterranean Fever Pharmaceuticals market, request a sample here.

What are the major opportunities in the Familial Mediterranean Fever Pharmaceuticals market? What are the strategies for the Familial Mediterranean Fever Pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Familial Mediterranean Fever Pharmaceuticals market, request a sample here.

How does the Familial Mediterranean Fever Pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Familial Mediterranean Fever Pharmaceuticals's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Familial Mediterranean Fever Pharmaceuticals industry?

For detailed insights on the mergers and acquisitions in the Familial Mediterranean Fever Pharmaceuticals industry, request a sample here.

What are the key dynamics influencing the Familial Mediterranean Fever Pharmaceuticals market growth? SWOT analysis of the Familial Mediterranean Fever Pharmaceuticals market.

For detailed insights on the key dynamics influencing the Familial Mediterranean Fever Pharmaceuticals market growth and SWOT analysis of the Familial Mediterranean Fever Pharmaceuticals industry, request a sample here.